Agenus (AGEN) Current Leases (2019 - 2026)
Agenus (AGEN) posted quarterly Current Leases of $1.1 million for Q1 2026, down 58.26% year-over-year from $2.5 million in Q1 2025, and up 1.93% quarter-over-quarter from $1.0 million in Q4 2025.
Agenus (AGEN) Current Leases (2019 - 2026) Analysis & Trends
Agenus' Current Leases history runs 8 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Current Leases fell 58.26% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (down 58.26% YoY), while the FY2025 annual figure was $1.0 million, down 57.73% from the prior year.
- Current Leases for Q1 2026 stood at $1.1 million, up from $1.0 million in the prior quarter.
- The five-year high for Current Leases was $9.4 million in Q2 2024, with the low at $766000.0 in Q2 2025.
- The 5-year median for Current Leases is $2.0 million (2023), against an average of $2.4 million.
- The sharpest annual moves came in 2024 and 2025: Current Leases surged 391.71% in 2024, then tumbled 91.82% in 2025.
- Agenus' Current Leases stood at $1.9 million in 2022, then soared by 33.14% to $2.6 million in 2023, then dropped by 5.45% to $2.4 million in 2024, then tumbled by 57.73% to $1.0 million in 2025, then increased by 1.93% to $1.1 million in 2026.
- Business Quant data shows AGEN's Current Leases at $1.1 million in Q1 2026, $1.0 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Agenus | 311.95 Mn | 286.43 Mn | 34.52 Mn | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Mn |
| Mar 31, 2026 | 1.05 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 766,000.00 |
| Mar 31, 2025 | 2.53 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 2.43 Mn |
| Jun 30, 2024 | 9.37 Mn |
| Mar 31, 2024 | 2.81 Mn |
| Dec 31, 2023 | 2.59 Mn |
| Sep 30, 2023 | 2.56 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | 1.97 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Sep 30, 2022 | 1.90 Mn |
| Jun 30, 2022 | 1.92 Mn |
| Mar 31, 2022 | 2.71 Mn |
| Dec 31, 2021 | 2.63 Mn |
| Sep 30, 2021 | 2.37 Mn |